Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Avricore Health ( (TSE:AVCR) ).
Avricore Health is expanding its HealthTab point-of-care testing platform across North East London, rolling out to an additional 70 community pharmacy sites following the success of its NHS-linked cardiovascular programmes with Barts Health NHS Trust. The move underscores growing national recognition of community pharmacies in cardiovascular care, aligns with NHS efforts to shift services from hospitals into the community, and demonstrates HealthTab’s scalability within complex NHS environments. By offering a turnkey, cloud-based infrastructure that integrates analyzers, patient results and quality-control data, and by partnering with reference lab CEQAL for rigorous quality management, Avricore is positioning HealthTab as a high-standard, scalable solution for preventive and treatment-linked care pathways across England.
The most recent analyst rating on (TSE:AVCR) stock is a Hold with a C$0.05 price target. To see the full list of analyst forecasts on Avricore Health stock, see the TSE:AVCR Stock Forecast page.
Spark’s Take on TSE:AVCR Stock
According to Spark, TipRanks’ AI Analyst, TSE:AVCR is a Neutral.
The score is driven primarily by weak financial performance (TTM revenue contraction, deep losses, and a return to free cash flow burn). Technicals are also soft with the price below major moving averages and slightly negative MACD. Valuation remains constrained by a negative P/E and no provided dividend yield.
To see Spark’s full report on TSE:AVCR stock, click here.
More about Avricore Health
Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies that advance pharmacy practice and patient care. Through its flagship HealthTab platform, a wholly owned subsidiary, the company aims to build the world’s largest network of rapid testing devices in community pharmacies, making actionable health information more accessible to patients while supporting the growing role of pharmacies in frontline healthcare delivery.
Average Trading Volume: 75,085
Technical Sentiment Signal: Sell
Current Market Cap: C$6.58M
For detailed information about AVCR stock, go to TipRanks’ Stock Analysis page.